BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17190625)

  • 1. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of patients with high-risk facial basal cell carcinoma treated with interferon.
    Sánchez V; Carpio E; Fardales VE; Martínez B; Arias AI; Brito E; Bermudez N; Rodríguez Y
    An Bras Dermatol; 2024; 99(3):391-397. PubMed ID: 38383261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aesthetic Reconstruction Based on Facial Subunit Principle for Basal Cell Carcinoma of the Face: A Retrospective Analysis.
    Mishra B; Mallik S; Agnihotry I; Behera J
    Cureus; 2024 Mar; 16(3):e56826. PubMed ID: 38654794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal cell carcinoma-a clinical indicator of immunosuppression.
    Scurtu LG; Petrica M; Scurtu F; Simionescu AA; Popescu MI; Simionescu O
    Front Med (Lausanne); 2024; 11():1381492. PubMed ID: 38549869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal Cell Carcinoma: Incidence and Trends in Valencia, Spain.
    García Ruiz R; Mateu Puchades A; Alegre de Miquel V
    Actas Dermosifiliogr; 2024 Mar; ():. PubMed ID: 38452894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of an atypical presentation of basal cell carcinoma of the nasal pyramid: Case report.
    Saout Arrih B; Bijou W; Oukessou Y; Rouadi S; Abada R; Mahtar M
    Int J Surg Case Rep; 2024 Apr; 119():109674. PubMed ID: 38704968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Clinical Efficacy between Electrodesiccation with Curettage and Application of 80% Phenol Solution in Treatment of Common Warts.
    Dalimunthe DA; Siregar R; Tanjung C
    Open Access Maced J Med Sci; 2018 Feb; 6(2):326-329. PubMed ID: 29531597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the recurrence rate of basal cell carcinoma.
    Bøgelund FS; Philipsen PA; Gniadecki R
    Acta Derm Venereol; 2007; 87(4):330-4. PubMed ID: 17598036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma.
    Kuijpers DI; Thissen MR; Berretty PJ; Ideler FH; Nelemans PJ; Neumann MH
    Dermatol Surg; 2007 May; 33(5):579-87. PubMed ID: 17451581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of vismodegib in advanced basal-cell carcinoma.
    Sekulic A; Migden MR; Oro AE; Dirix L; Lewis KD; Hainsworth JD; Solomon JA; Yoo S; Arron ST; Friedlander PA; Marmur E; Rudin CM; Chang AL; Low JA; Mackey HM; Yauch RL; Graham RA; Reddy JC; Hauschild A
    N Engl J Med; 2012 Jun; 366(23):2171-9. PubMed ID: 22670903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature.
    von Domarus H; Stevens PJ
    J Am Acad Dermatol; 1984 Jun; 10(6):1043-60. PubMed ID: 6736323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for Cost-Conscious Treatment of Basal Cell Carcinoma.
    Patel PV; Pixley JN; Dibble HS; Feldman SR
    Dermatol Ther (Heidelb); 2023 Sep; 13(9):1959-1971. PubMed ID: 37531073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma.
    Chen OM; Kim K; Steele C; Wilmas KM; Aboul-Fettouh N; Burns C; Doan HQ; Silapunt S; Migden MR
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management.
    Naik PP; Desai MB
    Oncol Ther; 2022 Dec; 10(2):317-335. PubMed ID: 35729457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Vismodegib Experience in Elderly Patients with Basal Cell Carcinoma: Case Reports and Review of the Literature.
    Passarelli A; Galdo G; Aieta M; Fabrizio T; Villonio A; Conca R
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin Cancers of the Auricle: A Retrospective Analysis of 41 Patients.
    Özgür E; Kamiloğlu U; Temiz P; Eskiizmir G
    Turk Arch Otorhinolaryngol; 2020 Sep; 58(3):169-173. PubMed ID: 33145501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and Future Trends in Molecular Biomarkers for Diagnostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin Cancer.
    Nikolouzakis TK; Falzone L; Lasithiotakis K; Krüger-Krasagakis S; Kalogeraki A; Sifaki M; Spandidos DA; Chrysos E; Tsatsakis A; Tsiaoussis J
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32899768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life and clinical and demographic characteristics of patients with cutaneous squamous cell carcinoma submitted to tumor resection by double-bladed scalpel.
    Barazzetti DO; Barazzetti PHO; Cavalheiro BT; Ely JB; Nunes DH; Stamm AMNF
    An Bras Dermatol; 2019 Jul; 94(3):304-312. PubMed ID: 31365659
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.